13F-HR filed by Knoll Capital Management, LLC
Knoll Capital Management, LLC filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 16 holding rows worth $193,229,000.
- Accession
- 0001144204-14-031318
- Filer
- CIK 1325083
- Filed
- 2014-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2014
A holdings report, 16 entries on the cover page, a total value of $193,229,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $193,229,000 with VALUE read as thousands by filing date, 13F file number 028-11424. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MEDIVATION INC | 58501N101 | COM | 2,279,519 | $146,733,000 | thousands by filing date | |
| Ampio Pharmaceuticals | 03209T109 | COM | 2,964,401 | $18,824,000 | thousands by filing date | |
| Alcobra Ltd | M2239P109 | SHS | 687,000 | $12,469,000 | thousands by filing date | |
| SYNTHETIC BIOLOGICS INC | 87164U102 | COM | 1,360,000 | $3,495,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 200,000 | $3,408,000 | thousands by filing date | |
| NEWLINK GENETICS CORP | 651511107 | COM | 77,437 | $2,199,000 | thousands by filing date | |
| NW Biotherapeutics | 66737P600 | USD | 200,300 | $1,450,000 | thousands by filing date | |
| INOVIO PHARMACEUTICALS I | 45773H102 | COM | 408,352 | $1,360,000 | thousands by filing date | |
| MERRIMACK PHARMACEUTICALS IN | 590328100 | COM | 160,585 | $809,000 | thousands by filing date | |
| GALMED PHARMACEUTICALS LTD | M47238106 | SHS | 65,000 | $746,000 | thousands by filing date | |
| Advaxis Inc. | 7624208 | COM NEW | 225,000 | $706,000 | thousands by filing date | The CUSIP as filed is malformed. |
| NEPHROGENEX INC | 640667101 | Cmn | 50,000 | $412,000 | thousands by filing date | |
| PARKERVISION INC | 701354102 | COM | 50,000 | $240,000 | thousands by filing date | |
| CELSUS THERAPEUTICS PLC | 15119A202 | COM | 23,255 | $151,000 | thousands by filing date | |
| Advaxis Inc. | 7624117 | W EXP 07/15/201 | 112,500 | $141,000 | thousands by filing date | The CUSIP as filed is malformed. |
| ECHO THERAPEUTICS INC | 27876L206 | COM NEW | 28,630 | $86,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-14-031318 | this filing | 2014-05-15 | acceptance time not in the bulk data set |